IART logo

Integra LifeSciences Holdings (IART) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

16 August 1995

Indexes:

Not included

Description:

Integra LifeSciences Holdings Corporation is a technology medical company whose main activity is the development, production, and sale of surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The Codman Specialty Surgical segment specializes in surgical products, including a wide range of surgical implants and instruments. The Orthopedics and Tissue Technologies segment focuses on regenerative technologies for the treatment of acute and chronic wounds; tools for surgical tissue regeneration, including hernia repair, peripheral nerve repair and protection, and tendon repair. The company was founded in 1989, with its headquarters in Princeton, New Jersey.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 04, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 04, 2017

Analyst ratings

Recent major analysts updates

05 Nov '24 Citigroup
Sell
14 Oct '24 Truist Securities
Hold
07 Oct '24 BTIG
Neutral
07 Oct '24 B of A Securities
Underperform
01 Oct '24 Citigroup
Sell
28 Aug '24 BTIG
Sell
22 Aug '24 Citigroup
Sell
30 July '24 Truist Securities
Hold
30 July '24 JMP Securities
Market Outperform
30 July '24 Citigroup
Sell

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
IART
zacks.com14 November 2024

According to a health economic evaluation, Integra's DuraSeal Dural Sealant is revealed to reduce healthcare costs.

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
IART
globenewswire.com13 November 2024

The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue

Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
IART
seekingalpha.com04 November 2024

Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2024 Earnings Call Transcript November 4, 2024 8:30 AM ET Company Participants Chris Ward - IR Stuart Essig - Executive Chairman Jan De Witte - President and CEO Lea Knight - CFO Conference Call Participants Steven Lichtman - Oppenheimer Vik Chopra - Wells Fargo Ryan Zimmerman - BTIG Kristen Stewart - C.L. King Robbie Marcus - JPMorgan Matt Taylor - Jefferies Richard Newitter - Truist Securities Craig Bijou - Bank of America Securities Joanne Wuensch - Citi Chris Ward Good morning and thank you for joining the Integra LifeSciences Third Quarter 2024 Earnings Conference Call.

Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
IART
zacks.com04 November 2024

Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.76 per share a year ago.

Integra LifeSciences Reports Third Quarter 2024 Financial Results
Integra LifeSciences Reports Third Quarter 2024 Financial Results
Integra LifeSciences Reports Third Quarter 2024 Financial Results
IART
globenewswire.com04 November 2024

PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024.

Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
IART
globenewswire.com04 November 2024

A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
IART
globenewswire.com14 October 2024

PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
IART
globenewswire.com04 September 2024

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.

Integra LifeSciences Continues to Make Progress on Its ESG Strategy
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
IART
globenewswire.com21 August 2024

The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring lives

Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
IART
zacks.com30 July 2024

Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.

FAQ

  • What is the primary business of Integra LifeSciences Holdings?
  • What is the ticker symbol for Integra LifeSciences Holdings?
  • Does Integra LifeSciences Holdings pay dividends?
  • What sector is Integra LifeSciences Holdings in?
  • What industry is Integra LifeSciences Holdings in?
  • What country is Integra LifeSciences Holdings based in?
  • When did Integra LifeSciences Holdings go public?
  • Is Integra LifeSciences Holdings in the S&P 500?
  • Is Integra LifeSciences Holdings in the NASDAQ 100?
  • Is Integra LifeSciences Holdings in the Dow Jones?
  • When was Integra LifeSciences Holdings's last earnings report?
  • When does Integra LifeSciences Holdings report earnings?
  • Should I buy Integra LifeSciences Holdings stock now?

What is the primary business of Integra LifeSciences Holdings?

Integra LifeSciences Holdings Corporation is a technology medical company whose main activity is the development, production, and sale of surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The Codman Specialty Surgical segment specializes in surgical products, including a wide range of surgical implants and instruments. The Orthopedics and Tissue Technologies segment focuses on regenerative technologies for the treatment of acute and chronic wounds; tools for surgical tissue regeneration, including hernia repair, peripheral nerve repair and protection, and tendon repair. The company was founded in 1989, with its headquarters in Princeton, New Jersey.

What is the ticker symbol for Integra LifeSciences Holdings?

The ticker symbol for Integra LifeSciences Holdings is NASDAQ:IART

Does Integra LifeSciences Holdings pay dividends?

No, Integra LifeSciences Holdings does not pay dividends

What sector is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Healthcare sector

What industry is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Medical Devices industry

What country is Integra LifeSciences Holdings based in?

Integra LifeSciences Holdings is headquartered in United States

When did Integra LifeSciences Holdings go public?

Integra LifeSciences Holdings's initial public offering (IPO) was on 16 August 1995

Is Integra LifeSciences Holdings in the S&P 500?

No, Integra LifeSciences Holdings is not included in the S&P 500 index

Is Integra LifeSciences Holdings in the NASDAQ 100?

No, Integra LifeSciences Holdings is not included in the NASDAQ 100 index

Is Integra LifeSciences Holdings in the Dow Jones?

No, Integra LifeSciences Holdings is not included in the Dow Jones index

When was Integra LifeSciences Holdings's last earnings report?

Integra LifeSciences Holdings's most recent earnings report was on 4 November 2024

When does Integra LifeSciences Holdings report earnings?

The next expected earnings date for Integra LifeSciences Holdings is 28 February 2025

Should I buy Integra LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions